RecruitingNot ApplicableNCT06576661

Evaluation of the LithoVue Elite Ureteroscope With Intra-Renal Pressure Monitoring Technology: Examination of Surgeon Behavior and Post-operative Outcomes

Sponsor

University of Kansas Medical Center

Enrollment

80 participants

Start Date

Jan 28, 2025

Study Type

INTERVENTIONAL

Conditions

Nephrolithiasis Kidney Stone

Summary

The goal of this study is to evaluate the influence of real-time intrarenal pressure measurement availability on surgeons' behavior during ureteroscopy while using the ureteroscope LithoVue Elite.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called INTRARENAL PRESSURE MONITORING VISIBLE for people with kidney stone and nephrolithiasis. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEINTRARENAL PRESSURE MONITORING VISIBLE

In Arm 1, participants will undergo URS with real-time IRP monitoring visible to surgeons using the LithoVue Elite™.

Locations(1)

University of Kansas Medical Center

Kansas City, Kansas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06576661

Related Trials

A Novel Ureteric Stent in Kidney Stone Patients and Oncology Patients Compared to a Conventional JJ Stent

NCT068151202 locations

HoYAG vs TFL in miniPCNL With ClearPetra

NCT070879771 location